Drug-eluting stents may lower reocclusion rates of CTOs Healio Researchers of a recent study have found that everolimus-eluting stents and conventional anterograde or retrograde approaches to chronic total occlusion are associated with very low rates of target vessel reocclusion, whereas subintimal tracking and ... |
